Off-label drug use in children

被引:0
|
作者
Jain S.S. [1 ]
Bavdekar S.B. [1 ,3 ]
Gogtay N.J. [2 ]
Sadawarte P.A. [1 ]
机构
[1] Department of Pediatrics, Seth GS Medical College, KEM Hospital, Parel, Mumbai
[2] Department of Clinical Pharmacology, Seth GS Medical College, KEM Hospital, Parel, Mumbai
[3] 9, A2 Worli Seaside CHS, Pujari Nagar, Worli, Mumbai 400018, KAG Khan Road
关键词
Drug use; Hospital-based Survey; Licensing; Pediatrics;
D O I
10.1007/s12098-008-0188-1
中图分类号
学科分类号
摘要
Objective: To determine the extent and nature of off-label drug use in children admitted to a pediatric general ward in a tertiary health care centre Methods: Consecutive patients aged 1 mo-12 years admitted to the general wards in a tertiary care center in Mumbai over a two-month period were prospectively enrolled in the study. British National Formulary [BNF] version 2005 was used to ascertain if the drug use was "off-label". The off-label use was categorized as: administration of a greater/lesser dose, administration at a higher/lower frequency than indicated, administration for indications not described, administration of a drug not licensed for use in that age group and/ or use of alternative routes of administration. Descriptive statistics was used for calculating the off-label drug use. Results: Two thousand prescriptions received by 600 subjects (M:F= 1.47:1) were analyzed. One thousand and forty-five (50.62%) prescriptions were off-label. The off-label drug use rate was 1.74+/-1.56 per patient. The maximum rate of off-label drugs was in infants (2.33/patient). 'alteration in dosage' was by far the commonest reason for off-label use; followed by 'age' and 'indication'. Furosemide (i. v.), diazepam (i.v), cefotaxime (i.v), ethambutol (tab) and prednisolone (tab) were the five commonest off-label drugs used in the study population. Conclusions: Off-label drug use was highly prevalent in general pediatric ward of a tertiary care hospital in India © 2008 Dr. K C Chaudhuri Foundation.
引用
收藏
页码:1133 / 1136
页数:3
相关论文
共 50 条
  • [31] Drug therapy in women: "Off-label use"?
    Thuermann, Petra A.
    [J]. PSYCHOPHARMAKOTHERAPIE, 2007, 14 (06): : 237 - 242
  • [32] EVALUATION AND MONITORING OF OFF-LABEL DRUG USE
    Danes, I
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 7 - 8
  • [33] Confounding Factors In Off-Label Drug Use
    Greenberg, Paul E.
    Pike, Crystal
    Sisitsky, Tammy
    [J]. HEALTH AFFAIRS, 2012, 31 (02) : 460 - 460
  • [34] Automated Detection of Off-Label Drug Use
    Jung, Kenneth
    LePendu, Paea
    Chen, William S.
    Iyer, Srinivasan V.
    Readhead, Ben
    Dudley, Joel T.
    Shah, Nigam H.
    [J]. PLOS ONE, 2014, 9 (02):
  • [36] On-label and off-label drug use in the treatment of endometriosis
    Quaas, Alexander M.
    Weedin, Elizabeth A.
    Hansen, Karl R.
    [J]. FERTILITY AND STERILITY, 2015, 103 (03) : 612 - 625
  • [37] Off-label use of antipsychotics: Rethinking "off-label"
    Groleger, Urban
    [J]. PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
  • [38] Evaluating the off-label use of medications in children
    Eiland, Lea S.
    Knight, Patrice
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (11) : 1062 - 1065
  • [39] Should off-label drug use be off-the-table?
    Rivkees, Scott A.
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2007, 20 (02): : 171 - 172
  • [40] The use of unlicensed and off-label medicines in children
    Conroy, S.
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A145 - A145